DBV Technologies S.A. (EPA:DBV)
France · Delayed Price · Currency is EUR 3.360
+0.020 (0.60%)
Apr 24, 2026, 4:43 PM CET
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of €988.59 million as of April 24, 2026. Its market cap has increased by 480.61% in one year.
Market Cap
988.59M
Enterprise Value
828.77M
Revenue
4.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.36
Market Cap Chart
Since March 29, 2012, DBV Technologies's market cap has increased from 79.23M to 988.59M, an increase of 1,147.77%. That is a compound annual growth rate of 19.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 992.14M | 46.31% |
| Dec 31, 2025 | 678.09M | 949.56% |
| Dec 31, 2024 | 64.61M | -63.70% |
| Dec 29, 2023 | 177.98M | -39.80% |
| Dec 30, 2022 | 295.62M | 75.76% |
| Dec 31, 2021 | 168.19M | -29.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.85B |
| Nanobiotix | 1.31B |
| Inventiva | 947.15M |
| MedinCell | 864.57M |
| Genfit | 440.69M |
| Valneva SE | 413.88M |
| Cellectis | 241.73M |
| Transgene | 206.51M |